{
    "2021-03-25": [
        [
            {
                "time": "2021-04-01",
                "original_text": "万泰生物(603392.SH)拟转让一无血清贴壁培养技术",
                "features": {
                    "keywords": [
                        "万泰生物",
                        "无血清贴壁培养技术",
                        "技术转让"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-04-01",
                "original_text": "万泰生物：将获得基于CHO ZN?ZF-修饰细胞系的新冠病毒蛋白扩增纯化筛选和生产技术",
                "features": {
                    "keywords": [
                        "万泰生物",
                        "新冠病毒蛋白",
                        "CHO ZN?ZF-修饰细胞系",
                        "生产技术"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药",
                        "疫苗研发"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-04-01",
                "original_text": "万泰生物(603392.SH)年度归母净利润同比增长224.13%至6.77亿元 每10股送4股派2.5元",
                "features": {
                    "keywords": [
                        "万泰生物",
                        "净利润增长",
                        "分红方案"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-04-01",
                "original_text": "万泰生物(603392.SH)拟续聘容诚会计师事务所为2021年度财务报告及内部控制审计机构",
                "features": {
                    "keywords": [
                        "万泰生物",
                        "容诚会计师事务所",
                        "审计机构"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-04-01",
                "original_text": "万泰生物：2020年净利润同比增长224% 拟10送4派2.5元",
                "features": {
                    "keywords": [
                        "万泰生物",
                        "净利润增长",
                        "分红方案"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-04-01",
                "original_text": "万泰生物(603392.SH)：将获得基于CHO ZN?ZF-修饰细胞系的新冠病毒蛋白扩增纯化筛选和生产技术",
                "features": {
                    "keywords": [
                        "万泰生物",
                        "新冠病毒蛋白",
                        "CHO ZN?ZF-修饰细胞系",
                        "生产技术"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药",
                        "疫苗研发"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-04-01",
                "original_text": "万泰生物(603392.SH)：与养生堂拟签订技术许可成本分摊协议",
                "features": {
                    "keywords": [
                        "万泰生物",
                        "养生堂",
                        "技术许可",
                        "成本分摊协议"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-04-01",
                "original_text": "万泰生物(603392.SH)：拟将基于U-2 OS细胞的无血清贴壁培养技术及知识产权转让给杭州养生堂",
                "features": {
                    "keywords": [
                        "万泰生物",
                        "杭州养生堂",
                        "无血清贴壁培养技术",
                        "知识产权转让"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-04-01",
                "original_text": "万泰生物(603392.SH)：2021年度拟向相关金融机构申请合计不超过9.4亿元综合授信额度",
                "features": {
                    "keywords": [
                        "万泰生物",
                        "金融机构",
                        "综合授信额度"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-04-01",
                "original_text": "中信证券：五粮液、万泰生物等5股的4月解禁市值超百亿元 解禁",
                "features": {
                    "keywords": [
                        "中信证券",
                        "五粮液",
                        "万泰生物",
                        "解禁市值"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药",
                        "白酒"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}